Wednesday, July 15, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
No Result
View All Result

Hulu’s ‘Dopesick’ tells the chilling story of America’s opioid crisis

Daily Remedy by Daily Remedy
October 15, 2021
in
0

In Hulu’s Dopesick, Michael Keaton plays Sam Finnix as the kind of family doctor anyone would want taking care of them.

Folksy and smart, he cares enough to stop by an elderly patient’s home after work to make sure she’s taken her medication. He’s still treating adults he delivered as babies in a small Virginia mining town.

But eventually, Finnix winds up in front of a grand jury, ashen and shell-shocked. When a prosecutor asks how his patients reacted to the drug OxyContin, he offers a chilling reply.

“I can’t believe how many of them are dead now.”

Source: NPR

https://www.npr.org/2021/10/14/1045904277/hulu-dopesick-michael-keaton-purdue-pharma-opioid

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

summary An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients. Chapters 00:00 Understanding Drug Pricing Dynamics 03:52 Exploring the Drug Pricing Database 10:07 Patient Advocacy and Drug Pricing 13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

No Result
View All Result

© 2026 Daily Remedy